HR 2146: DEFENDING PUBLIC SAFETY EMPLOYEES' RETIREMENT ACT - TITLE I: BIPARTISAN CONGRESSIONAL TRADE PRIORITIES AND ACCOUNTABILITY ACT OF 2015; PROVISIONS RELATED TO INTELLECTUAL PROPERTY HR 6: 21ST CENTURY CURES ACT; PROVISIONS RELATED TO PEDIATRIC RARE DISEASE PRIORITY REVIEW VOUCHER REVIEW/APPROVAL PROTOCOLS

HR 971: ORPHAN PRODUCT EXTENSIONS NOW ACCELERATING CURES AND TREATMENTS ACT OF 2015; PROVISIONS RELATED TO ORPHAN DRUG TAX CREDIT EXCLUSIVITY 

S 1421: ORPHAN PRODUCT EXTENSIONS NOW ACCELERATING CURES AND TREATMENTS ACT OF 2015; PROVISIONS RELATED TO ORPHAN DRUG TAX CREDIT EXCLUSIVITY 

S 1597: PATIENT-FOCUSED IMPACT ASSESSMENT ACT OF 2015; PROVISIONS RELATED TO PATIENT-FOCUSED DRUG DEVELOPMENT TOOLS
TRD - Trade (domestic/foreign) HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BIOMARIN PHARMACEUTICAL INC.
770 Lindaro Street, San Rafael, CA, 94901, US
TERICKE BLANCHARD (NONE) TERICKE BLANCHARD (NONE) KATHRYN LOWELL (N/A)
NONE NONE N/A